Virax Biolabs (VRAX) Equity Ratio (2021 - 2023)

Virax Biolabs (VRAX) has 3 years of Equity Ratio data on record, last reported at 0.91 in Q1 2023.

  • For Q1 2023, Equity Ratio rose 103.69% year-over-year to 0.91; the TTM value through Mar 2023 reached 0.91, up 103.69%, while the annual FY2023 figure was 0.91, 103.69% up from the prior year.
  • Equity Ratio reached 0.91 in Q1 2023 per VRAX's latest filing, up from 24.57 in the prior quarter.
  • Across five years, Equity Ratio topped out at 0.91 in Q1 2023 and bottomed at 24.57 in Q1 2022.
  • Average Equity Ratio over 3 years is 14.89, with a median of 20.99 recorded in 2021.
  • Peak YoY movement for Equity Ratio: decreased 17.03% in 2022, then soared 103.69% in 2023.
  • A 3-year view of Equity Ratio shows it stood at 20.99 in 2021, then fell by 17.03% to 24.57 in 2022, then surged by 103.69% to 0.91 in 2023.
  • Per Business Quant database, its latest 3 readings for Equity Ratio were 0.91 in Q1 2023, 24.57 in Q1 2022, and 20.99 in Q1 2021.